← Back to Search

Computer-assisted Behavior Intervention for Attention Deficit Hyperactivity Disorder (ADHD)

N/A
Waitlist Available
Led By Brandon Schultz, Ed.D.
Research Sponsored by East Carolina University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

The investigators will develop and pilot test an innovative computer-assisted behavior intervention (CABI) for middle school students with attention-deficit/hyperactivity disorder (ADHD). The CABI will deliver evidence-based behavior interventions for ADHD in a manner that is acceptable to teachers and motivating for students. The key element of the CABI is a serious game that will teach and encourage rehearsal of ADHD coping skills in an engaging game environment. Transfer of those skills to authentic education settings will be facilitated by teacher interventionists in consultation with school or clinical psychologists. The investigators will test the CABI condition (n = 18) against traditional teacher consultation for ADHD (n = 18) on measures of consultation fidelity and student academic and behavioral outcomes.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline on the Children's Organizational Skills Scale--Parent Report (COSS-P)
Change from baseline on the Classroom Performance Survey (CPS)
Change from baseline on the School Functioning Scale (SFS)
Secondary outcome measures
Change from baseline on the Working Alliance Inventory - Short Revised (WAI-SR)
Descriptive single-group analysis of Technology Acceptance Model Instrument - Fast Form
Group comparison of Satisfaction Questionnaire data
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Computer-assisted Behavior InterventionExperimental Treatment1 Intervention
A serious game paired with teacher consultation to address common needs related to ADHD in the classroom.
Group II: Challenging Horizons Program, School ConsultationActive Control1 Intervention
An established teacher consultation program to help teachers address ADHD in the classroom.

Find a Location

Who is running the clinical trial?

East Carolina UniversityLead Sponsor
107 Previous Clinical Trials
38,773 Total Patients Enrolled
Ohio UniversityOTHER
69 Previous Clinical Trials
37,178 Total Patients Enrolled
3 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
372 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Brandon Schultz, Ed.D.Principal InvestigatorEast Carolina University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Clinical Psychology & PsychotherapyJournal
Working Alliance Inventory-short Revised (WAI-SR): Psychometric Properties in Outpatients and Inpatients
Munder, Thomas, Fabian Wilmers, Rainer Leonhart, Hans Wolfgang Linster, and Jürgen Barth. 2009. “Working Alliance Inventory-short Revised (WAI-SR): Psychometric Properties in Outpatients and Inpatients”. Clinical Psychology & Psychotherapy. Wiley. doi:10.1002/cpp.658.
clinicaltrials.govStudy
Development of a Game-supported Intervention
2021. "Development of a Game-supported Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05048043.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top